• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL MASTERS SERIES HEART VALSALVA AORTIC VALVES GRAFT; HEART-VALVE, MECHANICAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL MASTERS SERIES HEART VALSALVA AORTIC VALVES GRAFT; HEART-VALVE, MECHANICAL Back to Search Results
Model Number 25VAVGJ-515
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Atrial Fibrillation (1729); Pericardial Effusion (3271)
Event Date 03/16/2023
Event Type  Injury  
Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
Clinical information: crd_992 - valved grafts pas, patient site id: (b)(6).It was reported that on 2023, a 25mm sjm masters series valsalva aortic valved graft was successfully implanted.No concomitant cardiac procedures were performed during the same surgery.There were no intraprocedural adverse events or device deficiencies reported.On 2023, the patient was discharged from hospital.On 2023, the patient was hospitalized for newly onset intermittent atrial fibrillation.On transthoracic echocardiogram, pericardial exudate was observed.A pericardiocentesis was performed urgently, and 700 ml of old, bloody fluid was drained.The patient was hospitalized from 2023, and then again from 2023.No patient consequences were reported.
 
Event Description
Clinical information: (b)(6) - valved grafts pas, patient site id: (b)(6).It was reported that on (b)(6) 2023, a 25mm sjm masters series valsalva aortic valved graft was successfully implanted.No concomitant cardiac procedures were performed during the same surgery.There were no intraprocedural adverse events or device deficiencies reported.On (b)(6) 2023, the patient was discharged from hospital and was on warfarin for anti-thrombotic treatment.On (b)(6) 2023, the patient was hospitalized for newly onset intermittent atrial fibrillation which was believed to be related to the implant procedure.The anti-arrhythmic medication amiodarone was administered.On transthoracic echocardiogram, pericardial exudate was observed.A pericardiocentesis was performed urgently, and 700 ml of old, bloody fluid was drained.The anti-thrombotic regimen was not adjusted after the pericardial effusion was detected and drained.The patient was hospitalized from (b)(6) 2023, and then again from (b)(6) 2023.No patient consequences were reported.
 
Manufacturer Narrative
An event of atrial fibrillation and pericardial effusion was reported.A returned device assessment could not be performed as the device remains implanted and was not returned for analysis.Information from the field indicated the reported event o was likely due to the implant procedure.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MASTERS SERIES HEART VALSALVA AORTIC VALVES GRAFT
Type of Device
HEART-VALVE, MECHANICAL
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ST. JUDE MEDICAL PUERTO RICO, INC. REG#2648612
20 b st caguas west park
caguas 00725
*   00725
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key16756714
MDR Text Key313488149
Report Number2135147-2023-01687
Device Sequence Number1
Product Code LWQ
Combination Product (y/n)N
Reporter Country CodeDA
PMA/PMN Number
P810002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 06/20/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/17/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/01/2023
Device Model Number25VAVGJ-515
Device Catalogue Number25VAVGJ-515
Device Lot Number8261268
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/12/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/11/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization; Life Threatening;
Patient Age58 YR
Patient SexMale
Patient Weight81 KG
Patient RaceWhite
-
-